drugset / Trial / NCT03267732
A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)
RandomizedParallel-groupOpen-labelOther
Summary
To evaluate the pharmacokinetics of single and multiple doses of pegilodecakin in healthy participants.
Timeline
- Start
- 2017-09-05
- Primary completion
- 2017-10-30
- Completion
- 2017-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pegilodecakin | Protein / enzyme biologic | 5 ug/kg | Subcutaneous |
| Comparator | Pegilodecakin | Protein / enzyme biologic | 10 ug/kg | Subcutaneous |
Indications
No indication recorded.